Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: results from the Phase 3 GEMINI 1 and 2 Trials

Authors
Category Primary study
ConferenceMultiple sclerosis journal
Year 2024
This article has no abstract
Epistemonikos ID: e2fb3b629e3a2d0cc2dbfcd5ebce8d72f2963561
First added on: Apr 04, 2026